Skip to main content
Toggle navigation
Search
Home
Back
Favorite
0
Like
Facebook
Print
An Overview of Regorafenib in Gastrointestinal Cancers: A Lunch Clinical Research Update
Regorafenib + IO agents: Why does site matter?
Saturday, July 2, 2022
13:45 – 14:00
Location: Rooms 133-134; Level 1
Session Speaker(s)
CB
Christophe Borg
Learning Objectives:
Talking Points: Biomarkers in regorafenib mCRC: (STC1 mono)